128 related articles for article (PubMed ID: 17939336)
1. IGF-1 is an independent risk factor for anemia in diabetic pre-dialysis patients.
Kim DH; Kim TY; Kim SM; Yoo SJ; Oh DJ; Yu SH
Korean J Intern Med; 2007 Sep; 22(3):186-91. PubMed ID: 17939336
[TBL] [Abstract][Full Text] [Related]
2. Effect of achieved hemoglobin level on renal outcome in non-dialysis chronic kidney disease (CKD) patients receiving epoetin beta pegol: MIRcerA CLinical Evidence on Renal Survival in CKD patients with renal anemia (MIRACLE-CKD Study).
Hayashi T; Uemura Y; Kumagai M; Kimpara M; Kanno H; Ohashi Y;
Clin Exp Nephrol; 2019 Mar; 23(3):349-361. PubMed ID: 30291472
[TBL] [Abstract][Full Text] [Related]
3. Hemoglobin stability in patients with anemia, CKD, and type 2 diabetes: an analysis of the TREAT (Trial to Reduce Cardiovascular Events With Aranesp Therapy) placebo arm.
Skali H; Lin J; Pfeffer MA; Chen CY; Cooper ME; McMurray JJ; Nissenson AR; Remuzzi G; Rossert J; Parfrey PS; Scott-Douglas NW; Singh AK; Toto R; Uno H; Ivanovich P
Am J Kidney Dis; 2013 Feb; 61(2):238-46. PubMed ID: 23159232
[TBL] [Abstract][Full Text] [Related]
4. Erythropoietic Response to Anaemia of Dialysis Naïve Patients with Chronic Kidney Disease in Zaria, North-West Nigeria.
Dogara LG; Hassan A; Awwalu S; Okpetu L; Waziri AD; Babadoko AA; Bosan IB; Muktar HM
Niger J Clin Pract; 2018 Feb; 21(2):189-194. PubMed ID: 29465053
[TBL] [Abstract][Full Text] [Related]
5. Low 1,25-dihydroxyvitamin D level is associated with erythropoietin deficiency and endogenous erythropoietin resistance in patients with chronic kidney disease.
Kim IY; Kim JH; Kim MJ; Lee DW; Hwang CG; Han M; Rhee H; Song SH; Seong EY; Lee SB
Int Urol Nephrol; 2018 Dec; 50(12):2255-2260. PubMed ID: 30136086
[TBL] [Abstract][Full Text] [Related]
6. Rationale and study design of a randomized controlled trial to assess the effects of maintaining hemoglobin levels using darbepoetin alfa on prevention of development of end-stage kidney disease in non-diabetic CKD patients (PREDICT Trial).
Imai E; Maruyama S; Nangaku M; Hirakata H; Hayashi T; Narita I; Kono H; Nakatani E; Morita S; Tsubakihara Y; Akizawa T
Clin Exp Nephrol; 2016 Feb; 20(1):71-6. PubMed ID: 26081567
[TBL] [Abstract][Full Text] [Related]
7. Renal anemia and hydration status in non-dialysis chronic kidney disease: Is there a link?
Hildegard Stancu S; Stanciu A; Lipan M; Capusa C
J Med Life; 2018; 11(4):293-298. PubMed ID: 30894885
[No Abstract] [Full Text] [Related]
8. Diabetes mellitus increases the severity of anemia in non-dialyzed patients with renal failure.
Ishimura E; Nishizawa Y; Okuno S; Matsumoto N; Emoto M; Inaba M; Kawagishi T; Kim CW; Morii H
J Nephrol; 1998; 11(2):83-6. PubMed ID: 9589379
[TBL] [Abstract][Full Text] [Related]
9. How the Target Hemoglobin of Renal Anemia Should Be.
Mimura I; Tanaka T; Nangaku M
Nephron; 2015; 131(3):202-9. PubMed ID: 26381503
[TBL] [Abstract][Full Text] [Related]
10. Effects of blood urea nitrogen independent of the estimated glomerular filtration rate on the development of anemia in non-dialysis chronic kidney disease: The results of the KNOW-CKD study.
Kim HJ; Kim TE; Han M; Yi Y; Jeong JC; Chin HJ; Song SH; Lee J; Lee KB; Sung S; Han SH; Seong EY; Ahn C; Oh KH; Chae DW
PLoS One; 2021; 16(9):e0257305. PubMed ID: 34506574
[TBL] [Abstract][Full Text] [Related]
11. [Impact of anemia correction on the production of the circulating morphogenetic protein α-Klotho in patients with Stages 3B-4 chronic kidney disease: A new direction of cardionephroprotection].
Milovanov YS; Mukhin NA; Kozlovskaya LV; Milovanova SY; Markina MM
Ter Arkh; 2016; 88(6):21-25. PubMed ID: 27296257
[TBL] [Abstract][Full Text] [Related]
12. Long-Term Efficacy and Safety of Molidustat for Anemia in Chronic Kidney Disease: DIALOGUE Extension Studies.
Akizawa T; Macdougall IC; Berns JS; Bernhardt T; Staedtler G; Taguchi M; Iekushi K; Krueger T
Am J Nephrol; 2019; 49(4):271-280. PubMed ID: 30852574
[TBL] [Abstract][Full Text] [Related]
13. Low erythropoietin levels predict faster renal function decline in diabetic patients with anemia: a prospective cohort study.
Fujita Y; Doi Y; Hamano T; Hatazaki M; Umayahara Y; Isaka Y; Tsubakihara Y
Sci Rep; 2019 Oct; 9(1):14871. PubMed ID: 31619722
[TBL] [Abstract][Full Text] [Related]
14. INSULIN-LIKE GROWTH FACTOR-1 AND ANEMIA IN OLDER SUBJECTS: THE INCHIANTI STUDY.
De Vita F; Maggio M; Lauretani F; Crucitti L; Bandinelli S; Mammarella F; Landi F; Ferrucci L; Ceda GP
Endocr Pract; 2015 Nov; 21(11):1211-8. PubMed ID: 26214107
[TBL] [Abstract][Full Text] [Related]
15. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
Tsubakihara Y; Nishi S; Akiba T; Hirakata H; Iseki K; Kubota M; Kuriyama S; Komatsu Y; Suzuki M; Nakai S; Hattori M; Babazono T; Hiramatsu M; Yamamoto H; Bessho M; Akizawa T
Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178
[TBL] [Abstract][Full Text] [Related]
16. Fibroblast Growth Factor 23 and Anemia in the Chronic Renal Insufficiency Cohort Study.
Mehta R; Cai X; Hodakowski A; Lee J; Leonard M; Ricardo A; Chen J; Hamm L; Sondheimer J; Dobre M; David V; Yang W; Go A; Kusek JW; Feldman H; Wolf M; Isakova T;
Clin J Am Soc Nephrol; 2017 Nov; 12(11):1795-1803. PubMed ID: 28784656
[TBL] [Abstract][Full Text] [Related]
17. C.E.R.A. maintains stable hemoglobin in Latin American patients on dialysis.
Bastos K; Lucarelli LA; De Francesco-Daher E; Filho RP; Henríquez C; Espinoza B; Villanueva I; Schwedt E; Schiavelli R; Correa-Rotter R
Int Urol Nephrol; 2013 Oct; 45(5):1355-64. PubMed ID: 22990412
[TBL] [Abstract][Full Text] [Related]
18. Serum Hepcidin and Iron Indices Affect Anemia Status Differently According to the Kidney Function of Non-Dialysis Chronic Kidney Disease Patients: Korean Cohort Study For Outcome in Patients with Chronic Kidney Disease (KNOW-CKD).
Lee SW; Kim YH; Chung W; Park SK; Chae DW; Ahn C; Kim YS; Sung SA
Kidney Blood Press Res; 2017; 42(6):1183-1192. PubMed ID: 29227972
[TBL] [Abstract][Full Text] [Related]
19. Practical approach to the diagnosis and treatment of anemia associated with CKD in elderly.
Agarwal AK
J Am Med Dir Assoc; 2006 Nov; 7(9 Suppl):S7-S12; quiz S17-21. PubMed ID: 17098634
[TBL] [Abstract][Full Text] [Related]
20. A Phase 3, Multicenter, Randomized, Two-Arm, Open-Label Study of Intermittent Oral Dosing of Roxadustat for the Treatment of Anemia in Japanese Erythropoiesis-Stimulating Agent-Naïve Chronic Kidney Disease Patients Not on Dialysis.
Akizawa T; Yamaguchi Y; Otsuka T; Reusch M
Nephron; 2020; 144(8):372-382. PubMed ID: 32580188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
